PenkeTrading Posted - 4 weeks ago

I found you an Oversold RSI (Relative Strength Index) on the daily chart of Collplant Biotechnologies Ltd. Is that bullish or bearish? $CLGN #Collplant #RsiOversold #NASDAQ

JimMacmara Posted - 09/25/24

$CLGN ets see some off the trend pretty bars Remember the sessions around the AZN stake increase on high volume... validates their tech

Fullratio Posted - 08/22/24

$CLGN revenue has plunged by 94% YoY and by 94% from the previous quarter: https://fullratio.com/stocks/nasdaq-clgn/collplant-biotechnologies

Thestocktraderhubzee Posted - 3 months ago

$CLGN HC Wainwright & Co. Reiterates Buy on CollPlant Biotechnologies, Maintains $11 Price Target

Thestocktraderhubzee Posted - 3 months ago

$CLGN EF Hutton Maintains Buy on CollPlant Biotechnologies, Maintains $14 Price Target

HaltTradeAlert Posted - 3 months ago

$CLGN Halt Time: 10:54:05 Issue Symbol: CLGN Reason Code: LUDP Last Price: $4.5 Volume: 6.5 K Members get this halt alert with no delay and with more info: shares outstanding, market cap, relative volume, and percentage change on the day. Also, halt alerts for pre-market hours and after market hours which is extremely important for Code T1 News Pending Alerts!! And free real time news catalyst alerts!

HaltTradeAlert Posted - 3 months ago

$CLGN Halt Time: 10:33:26 Issue Symbol: CLGN Reason Code: LUDP Last Price: $4.81 Volume: 2.1 K Members get this halt alert with no delay and with more info: shares outstanding, market cap, relative volume, and percentage change on the day. Also, halt alerts for pre-market hours and after market hours which is extremely important for Code T1 News Pending Alerts!! And free real time news catalyst alerts!

epsguid Posted - 3 months ago

$CLGN reported a loss of $0.73, consensus was ($0.35) via @eWhispers #epsmiss http://eps.sh/d/clgn

Stock_Titan Posted - 3 months ago

$CLGN $SSYS COLLPLANT BIOTECHNOLOGIES REPORTS 2024 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE https://www.stocktitan.net/news/CLGN/collplant-biotechnologies-reports-2024-second-quarter-financial-poi8k4rtl13s.html

Stock_Titan Posted - 3 months ago

$CLGN $SSYS CollPlant and Stratasys Announce Pre-clinical Study for Regenerative Commercial-Sized Breast Implants https://www.stocktitan.net/news/CLGN/coll-plant-and-stratasys-announce-pre-clinical-study-for-b67ngfkkr68x.html

Stock_Titan Posted - 3 months ago

$SSYS $CLGN CollPlant and Stratasys Announce Pre-clinical Study for Regenerative Commercial-Sized Breast Implants https://www.stocktitan.net/news/SSYS/coll-plant-and-stratasys-announce-pre-clinical-study-for-9ofkfw18k966.html

Stock_Titan Posted - 3 months ago

$CLGN COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 SECOND QUARTER FINANCIAL STATEMENTS AND CONFERENCE CALL INFORMATION https://www.stocktitan.net/news/CLGN/collplant-biotechnologies-announces-date-for-2024-second-quarter-3hmv0heiq838.html

PenkeTrading Posted - 3 months ago

I found you an Oversold RSI (Relative Strength Index) on the daily chart of Collplant Biotechnologies Ltd. Is that bullish or bearish? $CLGN #CLGN #nasdaq #tradingsignals #technicalanalysis

DonCorleone77 Posted - 5 months ago

$CLGN CollPlant bio-prints 200cc commercial-size regenerative breast implants CollPlant Biotechnologies has successfully printed for the first-time breast implants of 200 cc, which are commercial size. These implants were printed using CollPlant's proprietary rhCollagen bioinks. In addition, CollPlant announced additional, positive, interim preclinical data from ongoing large-animal studies, evaluating its regenerative breast implants. Currently there are no other commercial products that allow regeneration of soft tissues such as the breast. Additional positive data from CollPlant's pre-clinical studies that are currently underway show evidence of well-developed connective tissue containing blood vessels within the implant. An initial biodegradation process was observed, while preserving the original structure of the 3D breast implant. No adverse tissue reaction was observed. The most common breast augmentation or reconstruction procedures today are based on synthetic silicone breast implantations, an artificial substitution for natural regenerated tissue with risks of complications. CollPlant's rhCollagen-based, 3D-bioprinted breast implants are expected to regenerate breast tissue without eliciting immune response. In addition, CollPlant's regenerative breast implants have the potential to provide a novel solution for women in the need for breast reconstruction and augmentation. CollPlant expects to report topline data from an additional large-animal study to evaluate commercial-size versions of the 3D-bioprinted, regenerative breast implants, and an additional ongoing study, in Q4 of this year and Q1 of next year.

Stock_Titan Posted - 5 months ago

$CLGN CollPlant Successfully Bio-Prints 200cc Commercial-Size Regenerative Breast Implants and Reports Additional Positive Pre-Clinical Data https://www.stocktitan.net/news/CLGN/coll-plant-successfully-bio-prints-200cc-commercial-size-a32inb92g3ib.html

Fullratio Posted - 05/30/24

$CLGN current ratio has declined by 28% year-on-year and by 17% since the previous quarter: https://fullratio.com/stocks/nasdaq-clgn/collplant-biotechnologies

epsguid Posted - 05/29/24

$CLGN reported a loss of $0.37, consensus was ($0.35) via @eWhispers #epsmiss http://eps.sh/d/clgn

Stock_Titan Posted - 05/29/24

$CLGN CollPlant Biotechnologies Announces First Quarter Financial Results For 2024 and Provides Corporate Update https://www.stocktitan.net/news/CLGN/coll-plant-biotechnologies-announces-first-quarter-financial-results-sk5b86amjs9h.html

TheDizPlinTrader Posted - 05/29/24

$CLGN Detailed Analysis: 1-Hour Support & Resistance Zones 🚀 Current Price: $6.14 🔹 Support Levels: $5.93 - $5.76 Zone: This area has shown strong buying interest before, often acting as a buffer where buyers step in. Monitoring this zone can provide insights into potential rebounds. $5.59 - $5.36 Zone: Historically, this range has provided solid support, indicating a significant level where buyers have entered the market in force before. $5.00: This is a psychological level and a strong support from past consolidations, potentially serving as a critical defense point if the price falls. 🔸 Resistance Levels: $6.35 - $6.52 Zone: This level has acted as resistance previously, where selling pressure tends to emerge, halting the price rise. Observing reactions here can offer clues about potential breakouts or rejections. $6.69 - $6.92 Zone: This recent high and strong resistance level, if broken, can lead to a significant upward move, indicating bullish momentum. $7.30: A major resistance level aligning with previous highs. Breaking this point could open the way for a more extended rally. Earnings Report Prediction: Earnings could drive volatility. Watch $5.93 support and $6.35 resistance for potential trading opportunities. 🔍 Join our exclusive Discord community for in-depth analysis, real-time updates, expert insights, and live precise entry and exit updates. Unlock precise trading levels, strategies, and tips to take your trading to the next level. Visit my profile for the website link and more details. Let's trade smarter together!

Stock_Titan Posted - 6 months ago

$CLGN COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION https://www.stocktitan.net/news/CLGN/collplant-biotechnologies-announces-date-for-2024-first-quarter-09fgtgex4xyg.html

EBE_Day Posted - 6 months ago

$CLGN 💪💪💪

mikesterz7 Posted - 7 months ago

$CLGN Dermal filler program with AbbVie in clinical phase Regenerative breast implant program large-animal study underway to evaluate commercial-size implants with topline data expected in Q4 Ends 2023 with $26.7 million in cash and cash equivalents

DH_Explorer Posted - 7 months ago

$GRRR Hold GRRR, Hold $RELI or buy at $0.51, think about getting into $CLGN

DH_Explorer Posted - 7 months ago

$CLGN This alone should cause this stock to, pardon the pun, GROW SIZABLY! "Currently, there are no commercial products that allow regeneration of soft tissues such as the breast...CollPlant's proprietary plant-derived rhCollagen and other biomaterials, are expected to regenerate breast tissue without eliciting immune response, and therefore may provide a revolutionary alternative for aesthetic and reconstructive procedures....In addition, CollPlant's regenerative breast implants can be a novel solution for women in the breast reconstruction and augmentation market, which is sizeable, as it is the second most common plastic surgery procedure that is performed worldwide today." https://finance.yahoo.com/news/collplant-biotechnologies-reports-2023-full-110000410.html

epsguid Posted - 7 months ago

$CLGN reported a loss of $0.42 via @eWhispers http://eps.sh/d/clgn

Stock_Titan Posted - 7 months ago

$CLGN COLLPLANT BIOTECHNOLOGIES REPORTS 2023 FULL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE https://www.stocktitan.net/news/CLGN/collplant-biotechnologies-reports-2023-full-year-financial-results-4nugj4vbn16a.html

Stock_Titan Posted - 03/26/24

$CLGN COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION https://www.stocktitan.net/news/CLGN/collplant-biotechnologies-announces-date-for-2023-full-year-wb5hgzpetm2q.html

EBE_Day Posted - 8 months ago

$CLGN 👀🤞🍀

EBE_Day Posted - 8 months ago

$SSYS $CLGN watch out for this colab totake off - "In April of last year, we announced a joint development and commercialization agreement with Stratasys Ltd. to collaborate on the development of a solution to bio-fabricate human tissues and organs using Stratasys' P3 technology-based bioprinter and CollPlant's rh-Collagen-based bioinks. The first project focuses on the development of an industrial-scale solution for CollPlant's regenerative breast implants program. The new bioprinter, based on Stratasys' precise P3™ 3D printing technology in combination with CollPlant's flagship bioinks, is designed to enable the production of CollPlant's state of the art breast implants, which are being developed to regenerate an individual's natural breast tissue without eliciting immune response, providing a potentially revolutionary alternative for both aesthetic and reconstructive procedures."

TheTradeXchange Posted - 9 months ago

$CLGN - CollPlant Issues Letter to Shareholders